Chronotherapeutics and psychiatry: setting the clock to relieve the symptoms
At designated time intervals, 10 L of CCK-8 solution was added to each well, followed by incubation for 2 h
They represent the first time in the pharmacological history of obesity treatment that a drug trial has produced bariatric-surgery-level weight reduction at this scale, across 2,339 participants
Timing your protein shake consumption can significantly impact tolerability
Clinical trials on TGP also face certain challenges
Here are 8 potential reasons why not to prescribe Lixisenatide: 1- this is only one small study and only one dose was tested, 2- Lixisenatide is not currently available at pharmacies, 3- the weight loss associated with this GLP-1 is not desirable in many cases of Parkinsons disease where weight loss is an issue, 4- non-motor outcomes did not change as in other trials, and this will need to be better explained